Bone marrow-on-a-chip replicates hematopoietic niche physiology in vitro

Area of Science:

• Biomedical Engineering
• Hematology
• Stem Cell Biology

Background:

• Current in vitro models lack the complexity of living bone marrow, necessitating animal studies for hematologic research.
• Existing methods fail to replicate the cellular diversity and functional niche of native bone marrow.

Purpose of the Study:

• To develop a biomimetic 'bone marrow-on-a-chip' (eBM) model for in vitro studies.
• To enable the study of hematopoiesis and hematologic diseases with greater fidelity.
• To provide a platform for evaluating drug responses and toxicities in bone marrow.

Main Methods:

• Engineering new bone tissue in vivo.
• Whole bone explantation and perfusion within a microfluidic device.
• Culture of engineered bone marrow (eBM) to maintain hematopoietic stem and progenitor cells.

Main Results:

• The eBM model successfully retained hematopoietic stem and progenitor cells in normal proportions for over a week.
• eBM demonstrated organ-level marrow toxicity responses to simulated conditions.
• The model showed efficacy in evaluating protective effects of radiation countermeasure drugs.

Conclusions:

• The 'bone marrow-on-a-chip' provides a functional in vitro model of the hematopoietic niche.
• This biomimetic system advances the study of hematopoiesis, drug toxicity, and hematologic diseases.
• eBM offers a promising alternative to animal models for translational hematologic research.